RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta‐analysis of data from randomized placebo‐controlled trials

Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta‐analysis of data from randomized placebo‐controlled trials

Add to Collection
RCTs A Salsali, G Kim, HJ Woerle… - Diabetes, Obesity and …, 2016 - Wiley Online Library

Chapter : Section2
Journal Year : 2016
Cited by : 52

… with diabetes.1, … diabetes have approximately twice the risk of coronary heart disease, stroke and death resulting from other vascular causes compared with individuals without diabetes.…..... Read More

Keywords : ['randomize placebocontrolled trial', 'type diabetes', 'cardiovascular safety', 'patient', 'metaanalysis', 'empagliflozin', 'datum']
PubMed Link : https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.12734
Google Scholar Link : https://scholar.google.com/scholar?cites=3955373565966762045&as_sdt=2005&sciodt=0,5&hl=en&num=20